Medicare Enrolled
Dr. Sammy Moussly, M.D.
Hematology & Oncology · Winter Haven, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moussly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moussly?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moussly
Dr. Sammy Moussly is a hematology & oncology specialist in Winter Haven, FL, with 9 years of NPI registration. Based on federal Medicare data, Dr. Moussly performed 546 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Moussly received a total of $3,659 from 33 pharmaceutical and/or device companies across 136 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moussly is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years of NPI registration
▲ 546 Medicare services
$3,659 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 161005 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗546
Medicare services
Bottom 41% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
102 | $8 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
94 | $8 | $16 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $100 | $218 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
52 | $10 | $21 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
37 | $9 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $128 | $333 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
26 | $140 | $294 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
24 | $8 | $17 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $103 | $283 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
19 | $63 | $148 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
18 | $6 | $12 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
14 | $13 | $27 |
| Iron level test | 14 | $6 | $13 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
14 | $12 | $26 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
12 | $14 | $29 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $88 | $217 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$3,659
Total received (2018-2024)
Avg $523/year across 7 years
Bottom 47% in FL for hematology & oncology
33
Companies
136
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,071
2023
$873
2022
$220
2021
$124
2020
$20
2019
$236
2018
$114
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$307
Incyte Corporation
$198
Daiichi Sankyo Inc.
$166
PFIZER INC.
$164
Merck Sharp & Dohme LLC
$147
Gilead Sciences, Inc.
$122
Celgene Corporation
$115
AstraZeneca Pharmaceuticals LP
$98
Bayer Healthcare Pharmaceuticals Inc.
$90
Lilly USA, LLC
$89
Genentech USA, Inc.
$83
SOBI, INC
$82
ABBVIE INC.
$81
GENZYME CORPORATION
$54
Aveo Pharmaceuticals, Inc.
$48
TAIHO ONCOLOGY, INC.
$43
Janssen Biotech, Inc.
$36
JAZZ PHARMACEUTICALS INC.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$25
Pharmacosmos Therapeutics Inc.
$24
Spectrum Pharmaceuticals Inc.
$23
GlaxoSmithKline, LLC.
$21
Blueprint Medicines Corporation
$16
Verity Pharmaceuticals Inc.
$14
Top 3 companies account for 32.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$408
AstraZeneca Pharmaceuticals LP
$368
PFIZER INC.
$272
Daiichi Sankyo Inc.
$243
Incyte Corporation
$238
Kite Pharma, Inc.
$220
Merck Sharp & Dohme LLC
$198
Celgene Corporation
$186
GlaxoSmithKline, LLC.
$182
Bayer Healthcare Pharmaceuticals Inc.
$130
Genentech USA, Inc.
$129
ABBVIE INC.
$124
Gilead Sciences, Inc.
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$114
Lilly USA, LLC
$112
SOBI, INC
$82
Janssen Biotech, Inc.
$61
GENZYME CORPORATION
$54
Aveo Pharmaceuticals, Inc.
$48
AVEO Pharmaceuticals, Inc.
$45
TAIHO ONCOLOGY, INC.
$43
Blueprint Medicines Corporation
$33
Verity Pharmaceuticals Inc.
$28
JAZZ PHARMACEUTICALS INC.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$25
Pharmacosmos Therapeutics Inc.
$24
Spectrum Pharmaceuticals Inc.
$23
Seagen Inc.
$22
Myriad Genetic Laboratories, Inc.
$21
Novo Nordisk Inc
$20
E.R. Squibb & Sons, L.L.C.
$20
Agios Pharmaceuticals, Inc.
$20
Astellas Pharma US Inc
$16
Top 3 companies account for 28.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · BOSULIF · Columvi · DOPTELET · ERLEADA · Enhertu · FARXIGA · FOTIVDA · Fabhalta · ICLUSIG · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JARDIANCE · JAYPIRCA · KEYTRUDA · KISQALI · LONSURF · LUPRON DEPOT · LYNPARZA · MEKINIST · MONOFERRIC · MYRISK · Nubeqa · OJJAARA · OPDIVO · OXBRYTA · Ozempic · PLUVICTO · PYRUKYND · Pomalyst · REBLOZYL · ROLVEDON · RYBREVANT · SARCLISA · SCEMBLIX · SHINGRIX · TRELEGY ELLIPTA · Tecentriq · Trelstar · VENCLEXTA · VERZENIO · VONJO · Vanflyta · XTANDI · Xtandi · Yescarta · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
14
County median income
$63,644
Nearest hospital to ZIP centroid (approximate)
WINTER HAVEN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moussly is a clinical cardiology specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moussly experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Moussly performed 102 blood draw (venipuncture) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Moussly receive payments from pharmaceutical companies?
Yes. Dr. Moussly received a total of $3,659 from 33 companies across 136 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moussly's costs compare to other hematology & oncology specialists in Winter Haven?
Dr. Moussly's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moussly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Winter Haven
Browse hematology & oncology specialists in Winter Haven ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology